American Century Companies Inc. Sells 12,734 Shares of Encompass Health Co. (NYSE:EHC)

American Century Companies Inc. trimmed its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 3.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 404,918 shares of the company's stock after selling 12,734 shares during the quarter. American Century Companies Inc. owned approximately 0.40% of Encompass Health worth $37,395,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in EHC. State Street Corp increased its holdings in shares of Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company's stock worth $292,410,000 after buying an additional 21,329 shares in the last quarter. Geode Capital Management LLC grew its position in Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock worth $161,781,000 after acquiring an additional 20,547 shares during the last quarter. Copeland Capital Management LLC increased its holdings in Encompass Health by 0.7% in the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company's stock worth $119,418,000 after purchasing an additional 8,548 shares in the last quarter. Thrivent Financial for Lutherans raised its position in Encompass Health by 16.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 888,827 shares of the company's stock valued at $82,083,000 after purchasing an additional 128,331 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its stake in shares of Encompass Health by 2,458.5% during the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock valued at $83,990,000 after purchasing an additional 835,135 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on EHC shares. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp raised their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. Barclays increased their price objective on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, February 7th. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Finally, William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Encompass Health has a consensus rating of "Buy" and a consensus target price of $107.67.

Encompass Health Trading Down 0.0 %

Shares of Encompass Health stock traded down $0.01 on Tuesday, hitting $101.27. 486,266 shares of the company's stock traded hands, compared to its average volume of 645,880. The company has a market capitalization of $10.20 billion, a price-to-earnings ratio of 22.71, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company has a fifty day moving average of $98.92 and a two-hundred day moving average of $97.58. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a one year low of $78.53 and a one year high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, sell-side analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.